Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established ...
The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...
Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results